ZeroStack Corp. (ZSTK)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 9 | 33 | 76 | 60 | 36 | 40 | 30 |
| Operating profit | $m | -10 | -11 | ||||||
| Net profit | $m | -14 | -21 | -52 | -57 | -16 | -121 | -178 | - |
| EPS reported | $ | -43.49 | -120.3 | ||||||
| Operating cashflow per share | $ | -3.15 | -0.56 | ||||||
| Capex per share | $ | 0.05 | 0.00 | ||||||
| FCF per share | $ | -3.20 | -0.57 | ||||||
| Free cash flow | $m | -9 | -6 | ||||||
| Net debt | $m | 48 | -1 | ||||||
| Book value equity | $m | 71 | - | ||||||
| Book value per share | $ | 25.63 | 1.39 | ||||||
| Number of shares | m | 2.75 | 9.96 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.24 | 3.40 | ||||||
| P/S LTM | x | 0.48 | 0.43 | ||||||
| P/FCF LTM | x | -1.96 | -3.06 | ||||||
| EV/EBITDA LTM | x | -7.30 | -5.92 | ||||||
| EV/Sales LTM | x | 1.84 | 0.12 | ||||||
| Earnings Yield LTM | % | -7.01% | -3.79% | ||||||
| FCF Yield | % | -51.08% | -32.72% | ||||||
| Quality | |||||||||
| ROE | % | -171.29% | -382.27% | ||||||
| ROIC | % | -7.68% | -66.34% | ||||||
| Operating margin | % | -26.80% | -27.47% | ||||||
| Gross margin | % | -13.51% | -9.78% | ||||||
| FCF/Sales | % | -24.67% | -14.09% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -40.05% | -32.72% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.16 | -2.05 | ||||||
| Net Debt/EBITDA | x | -5.38 | 0.02 | ||||||
| EBIT/Net interest | x | -48.05 | -43.81 | ||||||
| Net debt/market cap | % | +3.11% | +51.33% | ||||||
| Net debt/Equity | x | 0.68 | - | ||||||
| Gross debt/equity | x | 0.76 | - | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free